| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.0092 | 1 |